Anti-malarial activity of N-6-modified purine analogues

Too, K; Brown, DM; Bongard, E; Yardley, V; Vivas, L; Loakes, D; (2007) Anti-malarial activity of N-6-modified purine analogues. Bioorganic & medicinal chemistry, 15 (16). pp. 5551-5562. ISSN 0968-0896 DOI:

Full text not available from this repository.


Plasmodium falciparum causes one of the deadliest forms of malaria and resistance to the currently available drugs makes it imperative to develop new, safe and potent drugs. Parasites such as P. falciparum are unable to synthesise purines de novo and to this end often have multiple purine uptake and salvage systems. With this in mind, we have designed and synthesised libraries of purine analogues as potential anti-malarial agents. Herein, we report three compounds with promising activity against the highly chloroquine-resistant VS1 P. falciparum namely: N-6-hydroxyadenine (1c), 2-amino-N-6-aminoadenosine (2b) and 2-amino-N-6-amino-N-6-methyladenosine (4b). (c) 2007 Elsevier Ltd. All rights reserved.

Item Type: Article
Keywords: Animals, Antimalarials, chemical synthesis, chemistry, toxicity, Male, Mice, Molecular Structure, Plasmodium falciparum, drug effects, Purines, chemical synthesis, chemistry, toxicity, Structure-Activity Relationship
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Immunology and Infection
Research Centre: Malaria Centre
PubMed ID: 17548196
Web of Science ID: 248172700020


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item